The estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis

Conclusion: It is difficult to determine the frequency of a “clinically significant aPL profile” in patients with aPL‐related clinical outcomes due to the lack of robust data. Our best estimates of the incidence of aPL‐associated events should be confirmed with appropriately designed population studies. © 2013 American College of Rheumatology.

Source: Arthritis Care and Research - July 16, 2013 Category: Rheumatology Authors: Laura Andreoli, Cecilia B. Chighizola, Alessandra Banzato, Guillermo J. Pons‐Estel, Guilherme Ramires de Jesus, Doruk Erkan, Tags: Brief Report Source Type: research